Xenon Pharmaceuticals Inc. · NASDAQ:XENE
Svoronos Dawn exercised options for 5,144 Xenon Pharmaceuticals Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Svoronos Dawn (Director) exercised options for 5,144 Xenon Pharmaceuticals Inc. shares at US$8.15 for US$41,924, leaving 31,373 shares. Filed Sep 3, 2026 (Form 4).
- Options exercised
- 5,144 shares
- Price
- US$8.15
- Value
- US$41,924
- Holding after
- 31,373 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Shares | Option exercise | 5,144 | US$8.15 | 31,373 | Direct |
Source
Related
- Xenon Pharmaceuticals Inc.
- Svoronos Dawn
- Xenon Pharmaceuticals Inc. shareholders
- Form 4 · Svoronos Dawn · Jun 3, 2026
- Form 4 · Kelly Thomas Patrick · Oct 16, 2026
- Form 4 · Kelly Thomas Patrick · Oct 1, 2026
- Form 4 · Mortimer Ian · Oct 1, 2026
- Form 4 · Kenney Christopher John · Aug 31, 2026
- Form 4 · Gannon Steven · Aug 13, 2026